Tag: Natera

Innovation, Research

Natera’s blood test detects breast cancer relapses

April 18, 2019


A blood test developed by Natera could detect early stage breast cancer relapse nearly two years quicker than current imaging technologies. Called Signatera, the test conducts molecular residual disease (MRD) analysis to identify trace amounts of mutated DNA produced by […]